
Milind Javle
@javlemilind
Hubert L and Olive Stringer Professor GI Medical Oncology and Attending Physician, MD Anderson Cancer Center
Chair, NCI Task Force Hepatobiliary Cancers
ID: 1357532036475596800
05-02-2021 03:30:48
920 Tweet
1,1K Followers
387 Following


Emerging evidence on use of ctDNA in CUP & biliary tract cancer for earlier detection, with ctDNA detection post surgery associated with worse RFS & OS in BTC ASCO #ASCO2025 Cholangiocarcinoma Foundation AMMF Alicia Conway


Thank you Ryan Denu, MD, PhD for always supporting every co-fellow and their posters!!! Excited to learn about spatial transcriptomics of sarcoma at your oral presentation tomorrow!


Our friend Sangeeta Goswami, MD,PhD with U2 The Edge # making cancer history MD Anderson Cancer Center


Milind Javle BALCO Medical Centre Prof Vikas Ostwal Tata Memorial Hospital Jarurat.care Cholangiocarcinoma Foundation MD Anderson Cancer Center Thank you for an inspiring visit to raipur ! We look forward working closely for BTC pts in india !



Proud for our star Eugene J. Koay, MD, PhD. Winner of MD Anderson Cancer Center Shark Tank! AI platform for liver directed therapy Cholangiocarcinoma Foundation


Great co-chairing this with Milind Javle Thank you for the phenomenal talk Rachna Shroff, MD, MS, FASCO ! And for the great cases Dr. Akash Tiwari - Medical Oncologist NIYATI SHAH, for the amazing panel discussions Dr. Prasad Raj Dandekar Soumil Vyas Prashant Kumar, CSO-DATAR CANCER GENETICS #DrDhavalThakkar All by Priyanka Joshi Jarurat.care 🙏🌺

Wonderful webinar Jarurat.care Cholangiocarcinoma Foundation


Thrilled to announce that after a highly competitive national search, Prajnan Das, MD, MS, MPH has been selected as the inaugural chair of GIRO Department MD Anderson Cancer Center. Looking forward to all the great things he will do in this new role. #rad onc #endcancer


“The lab and the clinic may seem like two different worlds, but when they come together, that’s where transformation happens — for science, for medicine, and most importantly, for patients." 5 reasons the physician-scientist path was right for me beckershospitalreview.com/oncology/5-rea… #


Daniel Ahn from Mayo Clinic Comprehensive Cancer Center presenting positive results for his study with #parp inhibitor Olaparib in #HRR #cholangiocarcinoma ESMO - Eur. Oncology #esmogi25 Cholangiocarcinoma Foundation Milind Javle Mitesh Borad, M.D.


Population-Specific Immunogenomic Alterations in Gallbladder Cancer: Differences between US and Chilean GBC: more ‘immune inflamed’ TME in the Latin American cohort Jarurat.care Cholangiocarcinoma Foundation ENS-CCA pubmed.ncbi.nlm.nih.gov/40541865/

Milind Javle Jarurat.care Cholangiocarcinoma Foundation ENS-CCA Mesmerizing findings on the differences in immune responses between populations! The #GallbladderCancer study you mentioned highlights how critical it is to consider diverse genetic backgrounds in cancer research, potentially leading to more tailored therapeutic strategies. How

Thank you Milind Javle for giving such an indepth talk on practical issues around FGFR inhibitors - amazing feedback from all over ! BALCO Medical Centre - molecular mdt is an amazing platform for all of us to learn and teach ! Dr Amol Akhade Dr Riyaz Shah MD Anderson Cancer Center Amol Patel

